From: Prognostic value of noggin protein expression in patients with resected gastric cancer
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age (>  70 vs. ≤ 70) | 2.203 | 1.497–3.270 | < 0.001 | 2.562 | 1.698–3.852 | < 0.001 |
Sex (female vs. male) | 1.172 | 0.771–1.793 | 0.460 |  |  | 0.404 |
T stage (T4 vs. T2/3) | 2.772 | 1.850–4.144 | < 0.001 | 1.560 | 0.940–2.581 | 0.085 |
N stage (N1–3 vs. N0) | 3.724 | 2.292–6.041 | < 0.001 | 3.007 | 1.663–5.461 | < 0.001 |
Lauren’s classification (non-intestinal vs. intestinal) | 1.334 | 0.898–1.962 | 0.154 |  |  | 0.675 |
Lymphatic invasion (yes vs. no) | 3.141 | 1.921–5.143 | < 0.001 | 1.481 | 0.790–2.789 | 0.219 |
Vascular invasion (yes vs. no) | 1.713 | 1.054–2.761 | 0.030 | 1.209 | 0.734–2.021 | 0.455 |
R0 resection (no vs. yes) | 2.662 | 1.552–4.580 | < 0.001 | 0.631 | 0.181–2.171 | 0.461 |
High Noggin, invasive front (yes vs. no) | 0.653 | 0.444–0.958 | 0.030 | 0.583 | 0.351–0.969 | 0.036 |
High Noggin, center lesion (yes vs. no) | 0.867 | 0.591–1.283 | 0.481 |  |  |  |
High RBPMS2, invasive front (yes vs. no) | 0.983 | 0.655–1.449 | 0.925 |  |  |  |
High RBPMS2, center lesion (yes vs. no) | 1.162 | 0.792–1.710 | 0.446 |  |  |  |
EBV positivity (yes vs. no) | 0.188 | 0.046–0.768 | 0.020 | 0.240 | 0.058–0.992 | 0.049 |
Peritoneal seeding (positive vs. negative) | 3.102 | 1.549–4.584 | < 0.001 | 2.065 | 0.588–7.231 | 0.256 |